- Home
- PMCB vs GSIW Comparison
PMCB vs GSIW Comparison
Compare PMCB & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- GSIW
- Stock Information
- Founded
- PMCB 1996
- GSIW 2016
- Country
- PMCB United States
- GSIW Hong Kong
- Employees
- PMCB N/A
- GSIW N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- GSIW
- Sector
- PMCB Health Care
- GSIW
- Exchange
- PMCB Nasdaq
- GSIW Nasdaq
- Market Cap
- PMCB 13.9M
- GSIW 13.0M
- IPO Year
- PMCB N/A
- GSIW 2023
- Fundamental
- Price
- PMCB $1.64
- GSIW $0.67
- Analyst Decision
- PMCB
- GSIW
- Analyst Count
- PMCB 0
- GSIW 0
- Target Price
- PMCB N/A
- GSIW N/A
- AVG Volume (30 Days)
- PMCB 57.4K
- GSIW 497.3K
- Earning Date
- PMCB 12-13-2024
- GSIW 11-26-2024
- Dividend Yield
- PMCB N/A
- GSIW N/A
- EPS Growth
- PMCB N/A
- GSIW N/A
- EPS
- PMCB 0.54
- GSIW N/A
- Revenue
- PMCB N/A
- GSIW $1,408,469.00
- Revenue This Year
- PMCB N/A
- GSIW N/A
- Revenue Next Year
- PMCB N/A
- GSIW N/A
- P/E Ratio
- PMCB $3.06
- GSIW N/A
- Revenue Growth
- PMCB N/A
- GSIW N/A
- 52 Week Low
- PMCB $1.39
- GSIW $0.63
- 52 Week High
- PMCB $2.58
- GSIW $15.99
- Technical
- Relative Strength Index (RSI)
- PMCB 40.27
- GSIW 33.50
- Support Level
- PMCB $1.72
- GSIW $0.63
- Resistance Level
- PMCB $1.94
- GSIW $0.95
- Average True Range (ATR)
- PMCB 0.17
- GSIW 0.11
- MACD
- PMCB -0.01
- GSIW 0.07
- Stochastic Oscillator
- PMCB 9.27
- GSIW 6.69
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.